{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:59:20Z","timestamp":1779256760917,"version":"3.51.4"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Limb-girdle muscular dystrophy 2E (LGMD 2E), recently renamed as autosomal recessive limb-girdle muscular dystrophy-4 (LGMDR4), is characterized by the lack of beta-sarcoglycan, normally expressed in skeletal muscles and cardiomyocytes. We hypothesized that progressive respiratory and left ventricular (LV) failure in LGMDR4 could be associated with the age and interrelated phenomena of the disease's natural history.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We conducted a retrospective review of the records of 26 patients with LGMDR4. Our primary objective was to compare the rates of decline among creatine phosphokinase (CPK) values, pulmonary function test (PFT) measures, and echocardiographic estimates and to relate them to patients' age.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The rates of decline\/year of CPK, PFTs, and LV function estimates are significatively bound to age, with the LV ejection fraction (EF) being the strongest independent variable describing disease progression. Moreover, the rate of decline of CPK, PFTs, and LV differed in patients grouped according to their genetic mutations, demonstrating a possible genotype\u2013phenotype correlation. The parallel trend of decline in CPK, PFT, and EF values demonstrates the presence in LGMDR4 of a simultaneous and progressive deterioration in muscular, respiratory, and cardiac function.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> This study expands the current knowledge regarding the trend of CPK values and cardiac and respiratory impairment in patients with LGMDR4, to optimize the monitoring of these patients, to improve their quality of life, and to provide clinical indices capable of quantifying the effects of any new gene or drug therapy.<\/jats:p>","DOI":"10.3389\/fneur.2021.657949","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T13:11:26Z","timestamp":1625145086000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical Determinants of Disease Progression in Patients With Beta-Sarcoglycan Gene Mutations"],"prefix":"10.3389","volume":"12","author":[{"given":"Giulia Bruna","family":"Marchetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvan","family":"Torrente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.nmd.2018.05.007","article-title":"229th ENMC international workshop: limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017","volume":"28","author":"Straub","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"B2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/(SICI)1097-4598(199804)21:4<421::AID-MUS1>3.0.CO;2-B","article-title":"From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy","volume":"21","author":"Ozawa","year":"1998","journal-title":"Muscle Nerve."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.3233\/JND-150105","article-title":"The classification, natural history and treatment of the limb girdle muscular dystrophies","volume":"2","author":"Murphy","year":"2015","journal-title":"J Neuromuscul Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/hmg\/5.12.1953","article-title":"Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMDR4)","volume":"5","author":"B\u00f6nnemann","year":"1996","journal-title":"Hum Mol Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/mus.10566","article-title":"Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan","volume":"29","author":"Shi","year":"2004","journal-title":"Muscle Nerve."},{"key":"B6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nrneurol.2016.35","article-title":"Limb-girdle muscular dystrophies - international collaborations for translational research","volume":"12","author":"Thompson","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/mus.24233","article-title":"Cardiac involvement in Dutch patients with sarcoglycanopathy: a cross-sectional cohort and follow-up study","volume":"50","author":"Schade van Westrum","year":"2014","journal-title":"Muscle Nerve."},{"key":"B8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijcard.2014.12.090","article-title":"Progression of cardiac involvement in patients with limb-girdle type 2 and Becker muscular dystrophies: a 9-year follow-up study","volume":"182","author":"Petri","year":"2015","journal-title":"Int J Cardiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0960-8966(02)00280-8","article-title":"LGMD2E patients risk developing dilated cardiomyopathy","volume":"13","author":"Fanin","year":"2003","journal-title":"Neuromuscul Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0960-8966(00)00174-7","article-title":"Evaluation of cardiac and respiratory involvement in sarcoglycanopathies","volume":"11","author":"Politano","year":"2001","journal-title":"Neuromuscul Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1136\/thx.53.11.949","article-title":"Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy","volume":"53","author":"Simonds","year":"1998","journal-title":"Thorax."},{"key":"B12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/mus.25192","article-title":"The italian limb girdle muscular dystrophy registry: relative frequency, clinical features, and differential diagnosis","volume":"55","author":"Magri","year":"2017","journal-title":"Muscle Nerve."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1093\/brain\/awaa228","article-title":"New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy","volume":"143","author":"Alonso-P\u00e9rez","year":"2020","journal-title":"Brain."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0153095","DOI":"10.1371\/journal.pone.0153095","article-title":"Natural history of cardiac and respiratory involvement, prognosis and predictive factors for long-term survival in adult patients with limb girdle muscular dystrophies type 2C and 2D","volume":"11","author":"Fayssoil","year":"2016","journal-title":"PLoS ONE."},{"key":"B15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.nmd.2017.02.011","article-title":"1st International workshop on clinical trial readiness for sarcoglycanopathies 15-16 November 2016, Evry, France","volume":"27","author":"Marsolier","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"B16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/(SICI)1097-4598(199904)22:4<473::AID-MUS8>3.0.CO;2-5","article-title":"Heart involvement in muscular dystrophies due to sarcoglycan gene mutations","volume":"22","author":"Melacini","year":"1999","journal-title":"Muscle Nerve."},{"key":"B17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/cge.13597","article-title":"Clinicogenetic lessons from 370 patients with autosomal recessive limb-girdle muscular dystrophy","volume":"96","author":"Winckler","year":"2019","journal-title":"Clin Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1212\/WNL.0000000000001519","article-title":"Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E","volume":"84","author":"Semplicini","year":"2015","journal-title":"Neurology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/21678707.2020.1865916","article-title":"Assessing diagnosis and managing respiratory and cardiac complications of sarcoglycanopathy","volume":"8","author":"Angelini","year":"2020","journal-title":"Expert Opinion on Orphan Drugs."},{"key":"B20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ppul.23172","article-title":"Characterization of pulmonary function in Duchenne muscular dystrophy","volume":"50","author":"Mayer","year":"2015","journal-title":"Pediatr Pulmonol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.nmd.2016.12.014","article-title":"Characterization of pulmonary function in 10-18 year old patients with Duchenne muscular dystrophy","volume":"27","author":"Meier","year":"2017","journal-title":"Neuromuscul Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1097\/00002060-199509001-00003","article-title":"Profiles of neuromuscular diseases. Duchenne muscular dystrophy","volume":"74","author":"McDonald","year":"1995","journal-title":"Am J Phys Med Rehabil."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/ppul.22765","article-title":"Quality of spirometry in 5-to-8-year-old children","volume":"48","author":"Gochicoa-Rangel","year":"2013","journal-title":"Pediatr Pulmonol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1164\/ajrccm.164.12.2103052","article-title":"Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy","volume":"164","author":"Phillips","year":"2001","journal-title":"Am J Respir Crit Care Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ymthe.2017.02.013","article-title":"Systemic AAV-mediated \u03b2-sarcoglycan delivery targeting cardiac and skeletal muscle ameliorates histological and functional deficits in LGMD2E mice","volume":"25","author":"Pozsgai","year":"2017","journal-title":"Mol Ther."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.657949\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T13:11:28Z","timestamp":1625145088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.657949\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":25,"alternative-id":["10.3389\/fneur.2021.657949"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.657949","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"article-number":"657949"}}